TD Cowen Maintains Buy Rating for AstraZeneca (AZN) Amid Strong Analyst Consensus
TD Cowen analyst Steve Scala has reaffirmed his "Buy" rating for AstraZeneca (AZN), signaling continued…
TD Cowen analyst Steve Scala has reaffirmed his "Buy" rating for AstraZeneca (AZN), signaling continued…